Concepedia

Changyu Wang

CW

Statistics

Publications

46

Citations

6.3K

H-Index

28

Active since

1995

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

Kaohsiung Chang Gung Memorial Hospital

Chang Gung University

Henan Agricultural University

Changyu Wang is an author at Huazhong University of Science and Technology specializing in oncology, medicine, and gynecologic oncology.

Publications per year

1995–2024

46

Publications

46

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2010 · 2.9K citations · Full text

Medicine, Oncology, Pharmacology +17

<i>In Vitro</i> Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and <i>In Vivo</i> Toxicology in Non-Human Primates

Changyu Wang, Kent Thudium, Minhua Han et al. · Cancer Immunology Research · 2014 · 592 citations

Life Sciences, Immunology, Oncology +17

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy

Xuexiang Du, Fei Tang, Mingyue Liu et al. · Cell Research · 2018 · 246 citations · Full text

Life Sciences, Immunology, Oncology +17

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology

Mark Selby, John Engelhardt, Robert J. Johnston et al. · PLoS ONE · 2016 · 228 citations · Full text

Medicine, Immunology, Oncology +17

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2023 · 220 citations

Medicine, Oncology, Pharmacology +17

1–5 of 46